No, BrdU (Bromodeoxyuridine) is not myelotoxic at labeling concentrations. This makes it a safe and effective tool for identifying and monitoring the proliferation of cancer cellsin-vivo. However, BrdU’s use for radiosensitizing is limited because it becomes myelosuppressive at radiosensitizing concentrations.